Skip to main content

investor_relations

Lakewood-Amedex CEO to Present at H.C. Wainwright Conference

Lakewood-Amedex CEO to Present at H.C. Wainwright Conference

Sarasota, Fla. – September 11, 2026 -- Lakewood-Amedex Biotherapeutics Inc. (NASDAQ: LABT) will present at the H.C. Wainwright 28th Annual Global Investment Conference in New York City from September 14-16, 2026.

CEO Kelvin Cooper to hold one-on-one investor meetings during three-day conference

Kelvin Cooper, Ph.D., chief executive officer of the clinical-stage biotechnology company, will deliver a virtual presentation and conduct one-on-one meetings with registered investors and potential partners. The sessions will cover Lakewood-Amedex's business and clinical development strategy, recent corporate achievements, and anticipated milestones.

U.S. Gold Corp. to Pitch CK Gold Project at Four September Investor Events

U.S. Gold Corp. to Pitch CK Gold Project at Four September Investor Events

Cheyenne, Wyoming – September 11, 2026 -- U.S. Gold Corp. (Nasdaq: USAU) will present its fully permitted CK Gold Project in Wyoming to investors at four separate conferences throughout September 2026, as the company seeks to build market awareness around a recently completed Feasibility Study.

Management targets four investor conferences across three U.S. cities

The company confirmed attendance at the Moody Capital Solutions Disruptive Growth & Life Sciences Conference in New York on September 9-10, followed by the H.C. Wainwright 28th Annual Global Investment Conference in New York from September 14-16. U.S. Gold will then travel to Colorado for the 2026 Precious Metals Summit in Beaver Creek, September 22-25, and Mining Forum Americas 2026 at The Broadmoor in Colorado Springs, September 27-30.